TGF-β is associated with poor prognosis and promotes osteosarcoma progression via PI3K/Akt pathway activation.

TGF-β is associated with poor prognosis and promotes osteosarcoma progression via PI3K/Akt pathway activation.
复制标题

DOI:
10.1080/15384101.2020.1805552
复制
发表时间:
2020-09
期刊:
Cell cycle (Georgetown, Tex.)
影响因子:
--
通讯作者:
Li W
Li W
中科院分区:
其他
文献类型:
--
作者:
Ma K;Zhang C;Li W

文献摘要

参考文献

被引文献

相似文献

转化生长因子β (TGF-β)是一种多功能细胞因子,在细胞增殖和分化中具有重要作用。TGF-β在多种类型的癌症中高表达,促进肿瘤侵袭和转移。然而,TGF-β在骨肉瘤进展中的作用尚不清楚。在本研究中,我们发现TGF-β在骨肉瘤细胞和组织中高表达,并与高Ennecking期(P = 0.033)、转移和复发相关。利用siRNA (si-TGF-β)构建TGF-β下调骨肉瘤细胞系。转染si-TGF-β的细胞增殖、迁移/侵袭和集落形成能力显著降低,细胞凋亡水平升高。此外,si-TGF-β处理降低了骨肉瘤细胞的球体大小、cd133阳性细胞比例以及SOX-2、Nanog和Oct-3/4的表达。在机制上,PI3K/mTOR磷酸化被TGF-β敲除抑制。25µM LY294002 (pi3k特异性抑制剂)预处理进一步增强了si-TGF-β诱导的骨肉瘤进展抑制。综上所述,这些结果揭示了TGF-β在骨肉瘤进展和干细胞相关性状调节中的新作用,并表明TGF-β可能作为治疗骨肉瘤的治疗靶点。
Transforming growth factor beta (TGF-β) is a multifunctional cytokine with important functions in cell proliferation and differentiation. TGF-β is highly expressed in several types of cancers and promotes tumor invasion and metastasis. However, the role of TGF-β in osteosarcoma progression is poorly understood. In the present study, we found that TGF-β is highly expressed in osteosarcoma cells and tissues, and is associated with high Ennecking stage (P = 0.033), metastasis, and recurrence. TGF-β-knockdown osteosarcoma cell lines were established using siRNA (si-TGF-β). Cells transfected with si-TGF-β exhibited significantly reduced proliferation, migration/invasion, and colony formation abilities, and increased levels of cell apoptosis. In addition, si-TGF-β treatment reduced spheroid size, the ratio of CD133-positive cells, and expression of SOX-2, Nanog, and Oct-3/4 in osteosarcoma cells. Mechanistically, PI3K/mTOR phosphorylation is inhibited by TGF-β knockdown. Pretreatment with 25 µM LY294002, a PI3K-specific inhibitor, further enhanced the si-TGF-β-induced suppression of osteosarcoma progression. Taken together, these results reveal a novel role for TGF-β in osteosarcoma progression and modulation of stemness-related traits and indicate that TGF-β may be of value as a therapeutic target for the treatment of osteosarcoma.
DOI: 10.1158/2159-8290.cd-19-0529
发表时间: 2020-01-01
期刊: CANCER DISCOVERY
影响因子: 28.2
作者:
Huang, Yun-Han;Hu, Jing;Massague, Joan
通讯作者: Massague, Joan
DOI: 10.1016/j.cbi.2018.09.013
发表时间: 2018-12-25
影响因子: 5.1
作者:
Sun, Yang;Jiang, Xiubo;Zhang, Qi
通讯作者: Zhang, Qi
DOI: 10.1016/j.jsbmb.2014.04.007
发表时间: 2015-02-01
影响因子: 4.1
作者:
Atif, Fahim;Yousuf, Seema;Stein, Donald G.
通讯作者: Stein, Donald G.
DOI: 10.1016/j.ijsu.2015.04.050
发表时间: 2015-08-01
影响因子: 15.3
作者:
Song, Ruipeng;Tian, Ke;Wang, Limin
通讯作者: Wang, Limin
通过控制软骨细胞分化和功能中TGF-β信号传导的调节,需要骨折愈合需要IFT80。
DOI: 10.1002/jbmr.3902
发表时间: 2020-03
期刊: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
影响因子: --
作者:
Liu M;Alharbi M;Graves D;Yang S
通讯作者: Yang S